# J-Star Holding (YMAT) — News YMAT · NASDAQ · Stock Canonical page: https://www.lighthorse.io/tickers/ymat/news ## Recent headlines - [Chinese Taiwan stocks fell in intraday trading, with YMAT down 18.7%, IMOS falling 4.5% and KBSX sliding 3.6%.](https://www.ainvest.com/news/chinese-taiwan-stocks-fell-intraday-trading-ymat-18-7-imos-falling-4-5-kbsx-sliding-3-6-2610-26) — AInvest Wire, Oct 13, 2026 Chinese Taiwan stocks experienced a decline in intraday trading on October 13, 2026, with several key equities showing notable downward movement. Among the most actively traded names, YMAT, the ticker for J-Star Holding Co. Ltd., fell by 18.7% , marking a sharp reversal from recent volatility seen… - [Trading released/resumed: Ymat) Reason not available](https://www.ainvest.com/news/trading-released-resumed-ymat-reason-2610-27) — AInvest Wire, Oct 12, 2026 On October 12, 2026, trading for J-Star Holding Co. (Nasdaq: YMAT) resumed following a prior halt, though the specific reason for the halt remains unavailable at this time. According to NASDAQ trading halt codes, a "Space" designation indicates that the cause for the halt has not been disclosed.… - [Trading released/resumed: (Ymat) Reason not available](https://www.ainvest.com/news/trading-released-resumed-ymat-reason-2610) — AInvest Wire, Oct 12, 2026 Trading in shares of J-Star Holding Co., Ltd. (NASDAQ: YMAT) resumed on October 12, 2026, following a period of market volatility. The stock closed at $2.03 per share, reflecting a 64.63% decline from its previous session’s close. The resumption of trading occurred without a publicly disclosed… - [Trading halted: (YMAT) Due to limit-up limit-down trading pause](https://www.ainvest.com/news/trading-halted-ymat-due-limit-limit-trading-pause-2610) — AInvest Wire, Oct 12, 2026 Trading in the stock of J-Star Holding Co., Ltd. (YMAT) was temporarily halted on October 12, 2026, due to the activation of a limit-up limit-down trading pause mechanism. This pause is triggered when a stock’s price moves beyond predefined thresholds within a short period, typically to allow for a… - [Quoin Pharmaceuticals Ltd: BTIG initiates coverage with buy rating; target price $14](https://www.ainvest.com/news/quoin-pharmaceuticals-btig-initiates-coverage-buy-rating-target-price-14-2610) — AInvest Wire, Oct 12, 2026 BTIG, a financial services firm, has initiated coverage on Quoin Pharmaceuticals Ltd with a "buy" rating and a target price of $14 per share. The recommendation reflects the firm’s assessment of the company’s current market position and potential for growth. While no detailed analysis or specific… --- Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express. This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness. Data provided by [AInvest](https://www.ainvest.com).